Expression of ER, PgR, HER1, HER2, and response: a study of preoperative chemotherapy-Reference-Cited by-同舟云学术

Expression of ER, PgR, HER1, HER2, and response: a study of preoperative chemotherapy

Published:2008-03 Issue:3 Volume:19 Page:465-472
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Colleoni M.,Viale G.,Zahrieh D.,Bottiglieri L.,Gelber R.D.,Veronesi P.,Balduzzi A.,Torrisi R.,Luini A.,Intra M.,Dellapasqua S.,Cardillo A.,Ghisini R.,Peruzzotti G.,Goldhirsch A.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/19/3/465/684070/mdm509.pdf

Reference30 articles.

1. Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastasis;Fisher;Cancer Res,1983

2. Oestrogen receptor status, pathological complete response and prognosis in patients receiving neoadjuvant chemotherapy for early breast cancer;Ring;Br J Cancer,2004

3. International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations;Kaufmann;J Clin Oncol,2003

4. Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: a study of preoperative treatment;Colleoni;Clin Cancer Res,2004

5. Chemotherapy response of breast cancer depends on HER-2 status and anthracycline dose intensity in the neoadjuvant setting;Petit;Clin Cancer Res,2001

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD10 expression as a potential predictor of pathological complete response in ER-negative and triple-negative breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy;Experimental and Molecular Pathology;2024-02

2. Preoperative Systemic Therapy for Breast Cancer;Surgical Clinics of North America;2023-02

3. Clinical features of patients with HER2-positive breast cancer and development of a nomogram for predicting survival;ESMO Open;2021-08

4. Are baseline mammographic and ultrasound features associated with metastasis free survival in women receiving neoadjuvant chemotherapy for invasive breast cancer?;European Journal of Radiology;2021-08

5. KI-67 LI Expression in Triple-Negative Breast Cancer Patients and Its Significance;Breast Cancer: Basic and Clinical Research;2021-01